Subsequently, we investigated the role of the interplay between NCAM and FGFR signalling using tumour tissue taken from a transgenic mouse model of ovarian cancer that expresses a high level of NCAM at the tumour boundary. Here, NCAM1 is linked to ovarian carcinoma.